Jun 15, 2026 08:02AM
Jun 15, 2026 08:00AM
Oct 29, 2024 08:00AM
Oct 22, 2024 08:00AM
Oct 3, 2024 08:00AM
Jul 31, 2024 08:00AM
Jul 29, 2024 08:12AM Grifols (GRFS) receives expanded XEMBIFY label in U.S., strengthening its Ig portfolio for patients
Jul 29, 2024 08:00AM
Jul 1, 2024 06:00AM
Jun 17, 2024 04:20AM
Nov 3, 2022 09:00AM
Feb 24, 2022 06:00AM
Nov 4, 2021 09:00AM
Oct 19, 2021 11:18AM Grifols and Egypt inaugurate first African plasma-supply platform, in Cairo, as part of the alliance to attain self-sufficiency in plasma-derived medicines
Jun 1, 2021 10:30AM
Apr 15, 2021 11:59AM
Mar 9, 2021 03:15AM
Oct 9, 2020 06:27AM
Oct 9, 2020 06:23AM
Jul 28, 2020 10:41AM
Jul 9, 2020 08:19AM Rigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in Europe
Jun 11, 2020 04:03AM
May 7, 2020 09:00AM
Apr 28, 2020 09:00AM
Apr 20, 2020 09:00AM
Mar 25, 2020 05:25PM
Dec 12, 2019 09:24AM
Dec 6, 2019 03:43PM Grifols (GRFS) presents its latest Alzheimer's clinical trial data
Dec 6, 2019 03:42PM
Nov 7, 2019 10:00AM
Jul 4, 2019 11:51AM
Feb 7, 2019 12:33PM
Feb 7, 2019 12:31PM
Jan 23, 2019 07:30AM
Jan 8, 2019 07:37AM Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions
Oct 12, 2018 09:50AM
Oct 8, 2018 02:57PM
Aug 16, 2018 08:00AM
Aug 14, 2018 08:00AM
Jun 19, 2018 08:25AM
Mar 5, 2018 09:00AM
Feb 6, 2018 09:45AM Grifols HyperRAB® (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection
Aug 1, 2017 08:00AM
May 9, 2017 10:05AM
May 9, 2017 10:00AM
Apr 24, 2017 08:00AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All